Methyl Donor-Rich Diet in the Postpartum Period
The Effect of a Methyl Donor-Rich Diet in the Postpartum Period on Maternal Depression Levels, Breastfeeding Success and Infant Weight: A Randomized Controlled Trial
1 other identifier
interventional
100
1 country
1
Brief Summary
This study aims to evaluate the effects of a methyl-donor-rich diet during the postpartum period on maternal depression, breastfeeding success, and infant weight. Postpartum women will first complete a three-day dietary record to assess their intake of selected nutrients involved in one-carbon metabolism, including folate, choline, betaine, methionine, vitamin B6, and vitamin B12. Women whose intake of at least one of these nutrients is below two-thirds of the applicable reference intake and who meet the other eligibility criteria will be eligible to participate. Eligible participants will be randomly assigned to one of two groups. The intervention group will receive an individualized methyl-donor-rich dietary program and nutrition education for two months. The control group will receive standard postpartum care and routine dietary advice. The study will compare the groups in terms of maternal depressive symptoms, breastfeeding success, and infant weight. Dietary intake will also be assessed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 21, 2026
CompletedFirst Submitted
Initial submission to the registry
October 15, 2026
CompletedFirst Posted
Study publicly available on registry
October 21, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
October 21, 2026
September 1, 2026
1.4 years
October 15, 2026
October 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Postpartum Depression Level (EPDS Score)
Maternal postpartum depression level will be assessed using the Edinburgh Postnatal Depression Scale (EPDS). The total EPDS score will be used to evaluate depressive symptoms, with higher scores indicating more severe symptoms.
At baseline and after 8 weeks of dietary intervention.
Breastfeeding Success (LATCH Score)
Breastfeeding success will be assessed using the LATCH breastfeeding assessment tool. The total LATCH score will be used to evaluate breastfeeding effectiveness.
At baseline and after 8 weeks of dietary intervention.
Infant Weight
Infant weight will be measured in kilograms and compared between the intervention and control groups.
At baseline and after 8 weeks of dietary intervention.
Study Arms (2)
Methyl Donor-Rich Dietary Intervention Group
EXPERIMENTALParticipants will receive an individualized methyl-donor-rich dietary program and nutrition education for two months, focusing on increasing the intake of foods rich in folate, choline, betaine, methionine, vitamin B6, and vitamin B12 through dietary modification without supplements.
Control Group
NO INTERVENTIONParticipants will receive standard postpartum care and routine dietary advice without the individualized methyl-donor-rich dietary intervention.
Interventions
An individualized methyl-donor-rich dietary program and nutrition education will be provided for two months. The intervention will focus on increasing the dietary intake of folate, choline, betaine, methionine, vitamin B6, and vitamin B12 through food-based dietary modifications without supplementation. Kitchen scales will be provided to support portion-size education.
Eligibility Criteria
You may qualify if:
- Women aged 18-40 years.
- Women presenting within the first 15 days after delivery.
- Mothers who had a term delivery (≥37 completed weeks of gestation).
- Mothers who are breastfeeding and whose infants are exclusively breastfed.
- No diagnosed psychiatric disorder or related medication use.
- No use of dietary supplements, including omega-3 supplements.
- No special diet program.
- No history of gestational diabetes, type 1 or type 2 diabetes, or insulin resistance.
- No malabsorption-related disorders, such as celiac disease or Crohn's disease.
- At least one assessed methyl donor nutrient intake below two-thirds of the applicable recommended intake, based on a 3-day dietary record.
- Willingness to participate voluntarily.
You may not qualify if:
- Development of serious postpartum complications, such as postpartum hemorrhage or sepsis.
- A maternal or infant health condition requiring prolonged hospitalization.
- Introduction of complementary foods to the infant during the study.
- Maternal smoking or alcohol use.
- Failure to adhere to the dietary intervention.
- Failure to attend follow-up assessments or voluntary withdrawal from the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Orhaneli Merkez Aile Sağlığı Merkezi
Bursa, Orhaneli̇, 16000, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
October 15, 2026
First Posted
October 21, 2026
Study Start
May 21, 2026
Primary Completion (Estimated)
October 1, 2027
Study Completion (Estimated)
December 1, 2027
Last Updated
October 21, 2026
Record last verified: 2026-09